Innospec (IOSP) Scheduled to Post Quarterly Earnings on Thursday

Innospec (NASDAQ:IOSP) is scheduled to be releasing its earnings data after the market closes on Thursday, May 9th. Analysts expect Innospec to post earnings of $1.63 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Innospec (NASDAQ:IOSP) last released its quarterly earnings data on Tuesday, February 13th. The specialty chemicals company reported $1.84 EPS for the quarter, beating the consensus estimate of $1.59 by $0.25. Innospec had a net margin of 7.14% and a return on equity of 13.69%. The firm had revenue of $494.70 million for the quarter, compared to the consensus estimate of $479.47 million. During the same period in the previous year, the company earned $1.20 earnings per share. The company’s quarterly revenue was down 3.1% on a year-over-year basis. On average, analysts expect Innospec to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Innospec Stock Performance

IOSP stock opened at $124.40 on Tuesday. The company’s 50-day simple moving average is $123.97 and its 200 day simple moving average is $117.04. Innospec has a 52 week low of $91.74 and a 52 week high of $131.18. The company has a market capitalization of $3.10 billion, a PE ratio of 22.33 and a beta of 1.11.

Insider Activity at Innospec

In related news, SVP David B. Jones sold 2,500 shares of the company’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $125.79, for a total value of $314,475.00. Following the transaction, the senior vice president now directly owns 9,664 shares in the company, valued at $1,215,634.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP David B. Jones sold 2,500 shares of the company’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $125.79, for a total value of $314,475.00. Following the transaction, the senior vice president now directly owns 9,664 shares in the company, valued at $1,215,634.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Leslie J. Parrette acquired 410 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The shares were purchased at an average cost of $123.96 per share, with a total value of $50,823.60. Following the transaction, the director now directly owns 3,620 shares of the company’s stock, valued at $448,735.20. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 36,500 shares of company stock worth $4,532,959. Corporate insiders own 1.35% of the company’s stock.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.